03 Jul 2026
Changes in systemic immune–inflammation index predict periprosthetic joint infection after hemiarthroplasty in elderly patients
J. Bone Joint Infect., 11, 387–394, 2026
06 Jul 2026
Literature review and case report on the use of rezafungin for spondylodiscitis in an outpatient parenteral antimicrobial therapy (OPAT) setting
J. Bone Joint Infect., 11, 395–400, 2026
09 Jul 2026
Management of fracture-related infection in low-resource settings in Africa: recommendations and guidelines from an international expert group
J. Bone Joint Infect., 11, 401–411, 2026
14 Jul 2026
Management and outcomes of culture-negative periprosthetic joint infection: a systematic review and meta-analysis
J. Bone Joint Infect., 11, 413–430, 2026
20 Jul 2026
Sonication fluid cultures enhance pathogen identification in fracture-related-infection (FRI)
J. Bone Joint Infect., 11, 431–440, 2026
28 Jul 2026
Bromelain and N-acetylcysteine (BromAc) as novel adjunctive therapy for prosthetic joint infection: a narrative review
J. Bone Joint Infect., 11, 441–451, 2026
31 Jul 2026
Rapid molecular culture versus conventional culture for periprosthetic joint infection: diagnostic performance and clinical relevance
J. Bone Joint Infect., 11, 453–462, 2026
03 Aug 2026
Timing from admission to debridement, antibiotic, and implant retention (DAIR) affects mortality risk in total hip prosthetic joint infections
J. Bone Joint Infect., 11, 463–477, 2026
03 Aug 2026
Culture-negative periprosthetic joint infection: an umbrella review of prevalence, diagnostic strategies, treatment, and methodological limitations
J. Bone Joint Infect., 11, 479–488, 2026
07 Aug 2026
Isolation policies in musculoskeletal infection care: time to move from tradition to evidence
J. Bone Joint Infect., 11, 489–492, 2026
13 Aug 2026
In vitro analysis of antiseptic solution effects on Staphylococcus aureus biofilms on orthopedic implant materials
J. Bone Joint Infect., 11, 493–501, 2026